Metformin: An Important Treatment Consideration for Persons with Prediabetes Taking Antipsychotics

Abstract

Get full access to this article

View all access options for this article.

References

Braga

Kraemer-Aguiar

Docherty

Le Roux

. Treating prediabetes: why and how should we do it? Minerva Med. 2019;110(1). doi:10.23736/S0026-4806.18.05897-4

Hostalek

Gwilt

Hildemann

. Therapeutic use of metformin in prediabetes and diabetes prevention. Drugs. 2015;75(10):1071-1094. doi:10.1007/s40265-015-0416-8

Hughes

Khan

Kirley

et al. Metformin prescription rates for patients with prediabetes. J Am Board Fam Med. 2022;35(4):821-826. doi:10.3122/jabfm.2022.04.210485

Entezari-Maleki

. Review of Prediabetes. JAMA. 2023;330(6):563. doi:10.1001/jama.2023.9956

Cernea

Dima

Correll

Manu

. Pharmacological management of glucose dysregulation in patients treated with second-generation antipsychotics. Drugs. 2020;80(17):1763-1781. doi:10.1007/s40265-020-01393-x

Hostalek

Campbell

. Metformin for diabetes prevention: update of the evidence base. Current Medical Research and Opinion. 2021;37(10):1705-1717. doi:10.1080/03007995.2021.1955667

Newcomer

Haupt

. The metabolic effects of antipsychotic medications. Can J Psychiatry. 2006;51(8):480-491. doi:10.1177/070674370605100803

De Silva

Suraweera

Ratnatunga

Dayabandara

Wanniarachchi

Hanwella

. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16(1):341. doi:10.1186/s12888-016-1049-5